These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 36754326)

  • 41. Removal of pharmaceuticals in urban wastewater: High rate algae pond (HRAP) based technologies as an alternative to activated sludge based processes.
    Villar-Navarro E; Baena-Nogueras RM; Paniw M; Perales JA; Lara-Martín PA
    Water Res; 2018 Aug; 139():19-29. PubMed ID: 29621714
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adsorption of pharmaceuticals from biologically treated municipal wastewater using paper mill sludge-based activated carbon.
    Silva CP; Jaria G; Otero M; Esteves VI; Calisto V
    Environ Sci Pollut Res Int; 2019 May; 26(13):13173-13184. PubMed ID: 30903474
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of pharmaceuticals in wastewater and removal using a membrane bioreactor.
    Radjenovic J; Petrovic M; Barceló D
    Anal Bioanal Chem; 2007 Feb; 387(4):1365-77. PubMed ID: 17115140
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modelling of micropollutant fate in hybrid growth systems: model concepts, Peterson matrix, and application to a lab-scale pilot plant.
    Mohammadi F; Bina B; Rahimi S; Janati M
    Environ Sci Pollut Res Int; 2022 Sep; 29(45):68707-68723. PubMed ID: 35545750
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Roles of ammonia-oxidizing bacteria in improving metabolism and cometabolism of trace organic chemicals in biological wastewater treatment processes: A review.
    Nsenga Kumwimba M; Meng F
    Sci Total Environ; 2019 Apr; 659():419-441. PubMed ID: 31096373
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Updated activated sludge model number 1 parameter values for improved prediction of nitrogen removal in activated sludge processes: validation at 13 full-scale plants.
    Choubert JM; Stricker AE; Marquot A; Racault Y; Gillot S; Héduit A
    Water Environ Res; 2009; 81(9):858-65. PubMed ID: 19860142
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potential of biochar filters for onsite sewage treatment: Adsorption and biological degradation of pharmaceuticals in laboratory filters with active, inactive and no biofilm.
    Dalahmeh S; Ahrens L; Gros M; Wiberg K; Pell M
    Sci Total Environ; 2018 Jan; 612():192-201. PubMed ID: 28850838
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ammonia-oxidizing communities in a highly aerated full-scale activated sludge bioreactor: betaproteobacterial dynamics and low relative abundance of Crenarchaea.
    Wells GF; Park HD; Yeung CH; Eggleston B; Francis CA; Criddle CS
    Environ Microbiol; 2009 Sep; 11(9):2310-28. PubMed ID: 19515200
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activated Sludge Production Parameters and Nutrient Content of Organic Sludge Components.
    Labelle MA; Dold PL; Gadbois A; Déléris S; Comeau Y
    Water Environ Res; 2017 Jan; 89(1):51-61. PubMed ID: 28236828
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathways and metabolites of microbial degradation of selected acidic pharmaceutical and their occurrence in municipal wastewater treated by a membrane bioreactor.
    Quintana JB; Weiss S; Reemtsma T
    Water Res; 2005 Jul; 39(12):2654-64. PubMed ID: 15979124
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fate of selected pharmaceuticals and synthetic endocrine disrupting compounds during wastewater treatment and sludge anaerobic digestion.
    Samaras VG; Stasinakis AS; Mamais D; Thomaidis NS; Lekkas TD
    J Hazard Mater; 2013 Jan; 244-245():259-67. PubMed ID: 23257325
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of solid retention time and nitrification capacity on the ability of activated sludge to remove pharmaceuticals.
    Falås P; Andersen HR; Ledin A; Jansen Jl
    Environ Technol; 2012; 33(7-9):865-72. PubMed ID: 22720411
    [TBL] [Abstract][Full Text] [Related]  

  • 53. First evidence for occurrence of hydroxylated human metabolites of diclofenac and aceclofenac in wastewater using QqLIT-MS and QqTOF-MS.
    Pérez S; Barceló D
    Anal Chem; 2008 Nov; 80(21):8135-45. PubMed ID: 18821734
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of a sequencing batch reactor sewage treatment rig for investigating the fate of radioactively labelled pharmaceuticals: Case study of propranolol.
    Popple T; Williams JB; May E; Mills GA; Oliver R
    Water Res; 2016 Jan; 88():83-92. PubMed ID: 26476679
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design strategy for a simultaneous nitrification/denitrification of a slaughterhouse wastewater in a Sequencing Batch Reactor: ASM2d modeling and verification.
    Filali-Meknassi Y; Auriol M; Tyagi RD; Comeau Y; Surampalli RY
    Environ Technol; 2005 Oct; 26(10):1081-100. PubMed ID: 16342532
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Removal of anti-inflammatory/analgesic pharmaceuticals from urban wastewater in a pilot-scale A
    Gallardo-Altamirano MJ; Maza-Márquez P; Peña-Herrera JM; Rodelas B; Osorio F; Pozo C
    Sci Total Environ; 2018 Dec; 643():1481-1492. PubMed ID: 30189564
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Degradation of pharmaceuticals from membrane biological reactor sludge with Trametes versicolor.
    Llorens-Blanch G; Badia-Fabregat M; Lucas D; Rodriguez-Mozaz S; Barceló D; Pennanen T; Caminal G; Blánquez P
    Environ Sci Process Impacts; 2015 Feb; 17(2):429-40. PubMed ID: 25563204
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of aged sludge bioaugmentation in two-stage activated sludge system to enhance the biodegradation of toxic organic compounds in high strength wastewater.
    Boonnorat J; Techkarnjanaruk S; Honda R; Angthong S; Boonapatcharoen N; Muenmee S; Prachanurak P
    Chemosphere; 2018 Jul; 202():208-217. PubMed ID: 29571141
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Occurrence and removal of pharmaceutically active compounds in sewage treatment plants with different technologies.
    Ying GG; Kookana RS; Kolpin DW
    J Environ Monit; 2009 Aug; 11(8):1498-505. PubMed ID: 19657534
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A review of the biotransformations of priority pharmaceuticals in biological wastewater treatment processes.
    Nguyen PY; Carvalho G; Reis MAM; Oehmen A
    Water Res; 2021 Jan; 188():116446. PubMed ID: 33038717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.